Virus Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Flu Vaccines
CSL Behring To Build High-Speed Syringe Fill Line at its Kankakee (Il) Facility
August 14th, 2007
CSL Behring announced plans to invest $15 million to expand its manufacturing facility here by adding a high-speed, single-dose syringe filling line. Plans call for the line to be operational in 2010, when the company intends to contract with its sister company, CSL Biotherapies, to provide filling and packaging services for seasonal influenza vaccine. CSL Biotherapies anticipates introducing its influenza vaccine to the U.S. beginning with the 2007/08 season. CSL Biotherapies has filed a Biologics License Application (BLA) with the U.S. Food and Drug Administration. The BLA requests that the vaccine be approved to immunize people 18 years of age and older. The approved...
Source: Virus Weekly (2007-08-14)
|
